Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2021 · 10-Q
Revenue$204.20M$204.20M+11.4% vs Q1 2020 Net Income$33.40M$33.40M+131.9% vs Q1 2020 EPS Diluted$0.83$0.83+124.3% vs Q1 2020 Gross Profit$137,731,000+16.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$66,009,000+62.8% Free Cash Flowderived$55,071,000+83.5% Margins · derivedGross margin67.4%+2.8 pt vs Q1 2020
Operating margin24.0%+5.9 pt vs Q1 2020
Net margin16.4%+8.5 pt vs Q1 2020
ended Sep 30, 2020 · filed Nov 9, 2020 · 40 d after period end